Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up

Bramlage, Peter; Gitt, Anselm K.; Schneider, Steffen; Deeg, Evelin; Tschöpe, Diethelm
December 2014
BMC Cardiovascular Disorders;2014, Vol. 14 Issue 1, p1
Academic Journal
Background In cases where antidiabetic monotherapy is unable to sufficiently control glucose levels in patients with type-2 diabetes, treatment needs to be intensified. Determining factors that may be predictors for the occurrence of comorbidities in these patients is essential for improving the efficacy of clinical diabetes care. Methods The DiaRegis prospective cohort study included 3,810 type-2 diabetics for whom the treating physician aimed to intensify and optimise antidiabetic treatment due to insufficient glucose control. Treatment intensification was defined as increasing the dose of the originally prescribed drug, and/or selecting an alternative drug, and/or prescribing an additional drug. The aims were to monitor the co-morbidity burden of type-2 diabetic patients over a followup of two years, and to identify multivariable adjusted predictors for the development of comorbidity and cardiovascular events. Results A total of 3,058 patients completed the 2 year follow-up. A substantial proportion of these patients had co-morbidities such as vascular disease, neuropathy, and heart failure at baseline. After treatment intensification, there was an increased use of DPP-4 inhibitors, insulin, and GLP-1 analogues, achieving reductions in HbA1c, fasting plasma glucose, and postprandial glucose. During the 2 year period 2.5% of patients (n = 75) died, 3.2% experienced non-fatal macrovascular events, 11.9% experienced microvascular events, and 4.3% suffered onset of heart failure. Predictors for combined macro-/microvascular complications/heart failure/death were found to be age (OR 1.36; 95%CI 1.10-1.68), prior vascular disease (1.73; 1.39-2.16), and history of heart failure (2.78; 2.10-3.68). Conclusions Determining the factors that contribute to co-morbidities during intensive glucose-lowering treatment is essential for improving the efficacy of diabetes care. Our results indicate that age, prior vascular disease, and heart failure constitute important predictors of poor cardiovascular outcomes in patients receiving such therapy.


Related Articles

  • Diabetes at the coalface: Management strategies for type 2 diabetes in Wales.  // Diabetes & Primary Care;2012, Vol. 14 Issue 4, p249 

    The article discusses about management strategies for type 2 diabetes in Wales. the author also tells that this is a report from the 3rd Welsh Conference of the Primary Care Diabetes Society, which took place on 10 May 2012 at the Parc Hotel by Thistle, Cardiff. This report was generated by the...

  • A Hatha Yoga Program for Type 2 Diabetes Mellitus: Considerations for Design and Implementation. Vizcaino, Maricarmen // Alternative & Complementary Therapies;Oct2014, Vol. 20 Issue 5, p243 

    The author discusses the use of Hatha yoga for patients with type 2 diabetes mellitus (T2DM), focusing on considerations for the design and implementation of the yoga program. It states that Hatha yoga is an ancient discipline that is composed of physical poses, breathing exercises and...

  • Prevalence of Complications and Clinical Audit of Management of Type 2 Diabetes Mellitus: A Prospective Hospital Based Study. KULSHRESTHA, MALINI; SETH, SEEMA; TRIPATHI, ASHUTOSH; SETH, ANINDITA; KUMAR, ANOOP // Journal of Clinical & Diagnostic Research;Nov2015, Vol. 9 Issue 11, p25 

    Introduction: Management of type 2 diabetes mellitus (DM) needs multi factorial risk reduction strategies like weight reduction, blood pressure (BP) control and lipid profile regulation, along with glycaemic control. These strategies should be implemented very early in the course of the disease...

  • Cardiovascular and major journals. Evans, Marc // Diabetes Digest;2015, Vol. 14 Issue 2, p98 

    The article presents abstracts related to glucose-lowering therapy to reduce the cardiovascular disease (CV) risks in patients with type 2 diabetes (T2D) which include the use of biguanides and liraglutide in risk reduction, and the impact of glycaemic index (GI) on the risk factors in CV disease.

  • Reversal of Movement Dysfunction Associated With Peripheral Neuropathy.  // Adapted Physical Activity Quarterly;Oct2012, Vol. 29 Issue 4, p369 

    A review of the article "Select exercise modalities may reverse movement dysfunction because of peripheral neuropathy," by L. Li and J.M. Hondzinski that appeared in the July 2012 issue of Exercise and Sport Science Reviews, is presented.

  • Effect of Early Multifactorial Therapy Compared With Routine Care on Microvascular Outcomes at 5 Years in People With Screen-Detected Diabetes: A Randomized Controlled Trial. Sandbæk, Annelli; Griffin, Simon J.; Sharp, Stephen J.; Simmons, Rebecca K.; Borch-Johnsen, Knut; Rutten, Guy E. H. M.; van den Donk, Maureen; Wareham, Nicholas J.; Lauritzen, Torsten; Davies, Melanie J.; Khunti, Kamlesh // Diabetes Care;Jul2014, Vol. 37 Issue 7, p2015 

    OBJECTIVE To determine the benefit of multifactorial treatment on microvascular complications among people with type 2 diabetes detected by screening. RESEARCH DESIGN AND METHODS This study was a multicenter cluster randomized controlled trial in primary care with randomization at the practice...

  • Meta-analysis shows limited benefit of lowering blood pressure below 130/80 mm Hg in patients with type 2 diabetes. Koraishy, Farrukh M.; Peixoto, Aldo J. // Evidence Based Medicine;Dec2013, Vol. 18 Issue 6, p222 

    The authors reflect on the study titled "Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis" by K. McBrien and colleagues published in a 2012 issue of the "Archives of Internal Medicine." Topics include risk of...

  • Tip 2 Diyabette Bifazik Analog Ä°nsülinler: Bir Tedavi ÖrneÄŸi ile Uzman Paneli Görüşleri. Akalın, Sema; Araz, Mustafa; Balcı, Mustafa Kemal; Çömlekçi, Abdurrahman; Damcı, Taner; Erbaş, Tomris; Satman, İlhan; Siva, Zeynep Oşar; Ünlühızarcı, Kürşat // Turkish Journal of Endocrinology & Metabolism;Sep2011, Vol. 15 Issue 3, p51 

    Recently, the prevalence of type 2 diabetes has reached pandemic levels all over the world, and the problem is still growing. Type 2 diabetes is a progressive disease, in which insulin resistance and decrease in beta cell function accompany obesity. Early disorder, which ensues in clinical...

  • Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes.  // Hospital Medicine Alert;Sep2013 Clinical Briefs in Primary Care, p18 

    The article discusses research on cardiovascular effects of intensive lifestyle intervention in patients with type 2 diabetes, with reference to a study published in "The New England Journal of Medicine" in 2013.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics